Two Effective Options, One Individualized Decision
If you’re considering medical weight loss, you’ve likely heard both semaglutide and tirzepatide mentioned. Both are effective, FDA-approved options, but they work a little differently. Here’s what to know before your visit with Dr. Silva:
- How they work: Semaglutide targets one hormone pathway (GLP-1). Tirzepatide targets two (GLP-1 and GIP), which is why it’s sometimes associated with greater average weight loss in studies.
- Both are proven effective: Clinical research shows meaningful, sustained weight loss with either medication when combined with lifestyle changes.
- Similar side effect profile: Nausea, vomiting, and digestive changes are the most common side effects with both medications, especially early on or after a dose increase.
- Administration: Both are typically given as a once-weekly injection, with your dose gradually adjusted over time under physician supervision.
- There’s no universal “better” option: The right choice depends on your health history, how your body responds, and your specific goals — which is exactly what Dr. Silva evaluates with you directly.
- You’re not locked in: If one medication isn’t the right fit, adjustments can be made under Dr. Silva’s direct supervision, not guesswork.
The best way to know which option is right for you is a real conversation with a doctor who’s evaluating your health, not a generic recommendation. Let SilvaCare help you make this decision with confidence.